Aurobindo Pharma gets USFDA nod for infections treatment drug
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin Oral suspension 100 mg /5 mL and 200 mg/5 mL.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Azithromycin | Biotechnology | Food and Drug Administration (FDA) | Pharmaceuticals | Zithromax